Truncated recombinant Puumala virus nucleocapsid proteins protect mice against challenge in vivo

Viral Immunology

Volumn 21, Issue 1, 2008, Pages 49-60

  Maes, Piet ^a   Clement, Jan ^a   Cauwe, Bénédicte ^a   Bonnet, Véronique ^b   Keyaerts, Els ^a   Robert, Alain ^a   Van Ranst, Marc ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CARRIER PROTEIN; NUCLEOCAPSID PROTEIN; OUTER MEMBRANE PROTEIN A; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; TRYPTOPHAN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLONE; DENDRITIC CELL; ESCHERICHIA COLI; IMMUNIZATION; IMMUNOGENICITY; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; MOLECULE; MOUSE; MUTANT; NONHUMAN; PROTEIN EXPRESSION; PUUMALA VIRUS; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC FEVER WITH RENAL SYNDROME; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; LUNG; MALE; MICE; NUCLEOCAPSID PROTEINS; PUUMALA VIRUS; RECOMBINANT PROTEINS;

DOBRAVA-BELGRADE VIRUS; KLEBSIELLA PNEUMONIAE; MUS; PUUMALA VIRUS;

EID: 41349103948     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2007.0059     Document Type: Article

References (42)

1. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, and Koup RA: Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281:65-78.
2. Bharadwaj M, Lyons CR, Wortman IA, and Hjelle B: Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice. Vaccine 1999;17:2836-2843.
3. Chevalet L, Robert A, Gueneau F, Bonnefoy JY, and Nguyen T: Recombinant protein production driven by the tryptophan promoter is tightly controlled in ICONE 200, a new genetically engineered E. coli mutant. Biotechnol Bioeng 2000;69:351-358.
4. Cho HW, Howard CR, and Lee HW: Review of an inactivated vaccine against hantaviruses. Intervirology 2002;45:328-333.
5. Choi Y, Ahn CJ, Seong KM, Jung MY, and Ahn BY: Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells. Vaccine 2003;21:1867-1873.
6. Chu YK, Jennings GB, and Schmaljohn CS: A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. J Virol 1995;69:6417-6423.
7. Clement J, Heyman P, McKenna P, Colson P, and Avsic-Zupanc T: The hantaviruses of Europe: From the bedside to the bench. Emerg Infect Dis 1997;3:205-211.
8. Clement J, Maes P, and Van Ranst M: Hantaviruses in the Old and New World. In: Perspectives in Medical Virology: Emerging Viruses in Human Populations. (Tabor E, ed.). Elsevier, London, 2006.
9. Dargeviciute A, Brus SK, Sasnauskas K, Kruger DH, Meisel H, Ulrich R, and Lundkvist A: Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model. Vaccine 2002;20:3523-3531.
10. de Carvalho NC, Gonzalez D, Padula VP, Bjorling E, Plyusnin A, and Lundkvist A: Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses. J Virol 2002;76:6669-6677.
11. Elgh F, Linderholm M, Wadell G, Tarnvik A, and Juto P: Development of humoral cross-reactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica. FEMS Immunol Med Microbiol 1998;22:309-315.
12. Elgh F, Lundkvist A, Alexeyev OA, Wadell G, and Juto P: A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus. J Virol Methods 1996;59:161-172.
13. Geldmacher A, Schmaler M, Kruger DH, and Ulrich R: Yeast-expressed hantavirus Dobrava nucleocapsid protein induces a strong, long-lasting, and highly cross-reactive immune response in mice. Viral Immunol 2004;17:115-122.
14. Haeuw JF, Rauly I, Zanna L, et al.: The recombinant Klebsiella pneumoniae outer membrane protein OmpA has carrier properties for conjugated antigenic peptides. Eur J Biochem 1998;255:446-454.
15. Hooper JW, Kamrud KI, Elgh F, Custer D, and Schmaljohn CS: DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection. Virology 1999;255:269-278.
16. Huggins JW, Hsiang CM, Cosgriff TM, et al.: Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991;164:1119-1127.
17. Jeannin P, Bottazzi B, Sironi M, et al.: Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 2005;22:551-560.
18. Kamrud KI, Hooper JW, Elgh F, and Schmaljohn CS: Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters. Virology 1999;263:209-219.
19. Klingstrom J, Maljkovic I, Zuber B, Rollman E, Kjerrstrom A, and Lundkvist A: Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge. Vaccine 2004;22:4029-4034.
20. Koletzki D, Lundkvist A, Sjolander KB, et al.: Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles. Virology 2000;276:364-375.
21. Koletzki D, Schirmbeck R, Lundkvist A, Meisel H, Kruger DH, and Ulrich R: DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection. J Biotechnol 2001;84:73-78.
22. Kruger DH, Ulrich R, and Lundkvist AA: Hantavirus infections and their prevention. Microbes Infect 2001;3:1129-1144.
23. Libon C, Haeuw JF, Crouzet F, Mugnier C, Bonnefoy JY, Beck A, and Corvaia N: Streptococcus pneumoniae polysaccharides conjugated to the outer membrane protein A from Klebsiella pneumoniae elicit protective antibodies. Vaccine 2002;20:2174-2180.
24. Linderholm M, and Elgh F: Clinical characteristics of hantavirus infections on the Eurasian continent. Curr Top Microbiol Immunol 2001;256:135-151.
25. Lundkvist A, Kallio-Kokko H, Sjolander KB, Lankinen H, Niklasson B, Vaheri A, and Vapalahti O: Characterization of Puumala virus nucleocapsid protein: Identification of B-cell epitopes and domains involved in protective immunity. Virology 1996;216:397-406.
26. Maes P, Clement J, Gavrilovskaya I, and Van Ranst M: Hantaviruses: Immunology, treatment, and prevention. Viral Immunol 2004;17:481-497.
27. Maes P, Keyaerts E, Bonnet V, Clement J, Avsic-Zupanc T, Robert A, and Van Ranst M: Truncated recombinant Dobrava hantavirus nucleocapsid proteins induce strong, long-lasting immune responses in mice. Intervirology 2006;49:253-260.
28. Maes P, Keyaerts E, Clement J, Bonnet V, Robert A, and Van Ranst M: Detection of Puumala hantavirus antibody with ELISA using a recombinant truncated nucleocapsid protein expressed in Escherichia coli. Viral Immunol 2004;17:315-321.
29. Maes P, Li S, Verbeeck J, Keyaerts E, Clement J, and Van Ranst M: Evaluation of the efficacy of disinfectants against Puumala hantavirus by real-time RT-PCR. J Virol Methods 2006;141:111-115.
30. Nguyen TN, Samuelson P, Sterky F, et al.: Chromosomal sequencing using a PCR-based biotin-capture method allowed isolation of the complete gene for the outer membrane protein A of Klebsiella pneumoniae. Gene 1998;210:93-101.
31. Niklasson B, and Kjelsson T: Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay. J Clin Microbiol 1988;26:1519-1523.
32. Power UF, Plotnicky-Gilquin H, Huss T, et al.: Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment. Virology 1997;230:155-166.
33. Rauly I, Goetsch L, Haeuw JF, Tardieux C, Baussant T, Bonnefoy JY, and Corvaia N: Carrier properties of a protein derived from outer membrane protein A of Klebsiella pneumoniae. Infect Immun 1999;67:5547-5551.
34. Rizvanov AA, van Geelen AG, Morzunov S, Otteson EW, Bohlman C, Pari GS, and St Jeor SC: Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein. J Virol 2003;77:12203-12210.
35. Schmaljohn C, and Hjelle B: Hantaviruses: A global disease problem. Emerg Infect Dis 1997;3:95-104.
36. Settergren B, Ahlm C, Juto P, and Niklasson B: Specific Puumala IgG virus half a century after haemorrhagic fever with renal syndrome. Lancet 1991;338:66.
37. Soulas C, Baussant T, Aubry JP, et al.: Outer membrane protein A (OmpA) binds to and activates human macrophages. J Immunol 2000;165:2335-2340.
38. Suni MA, Picker LJ, and Maino VC: Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods 1998;212:89-98.
39. Tkachenko EA, Bashkirtsev VN, van der GG, Dzagurova TK, Ivanov AP, and Ryltseva EV: Isolation in Vero-E6 cells of Hanta virus from Clethrionomys glareolus captured in the Bashkiria area of the U.S.S.R. Ann Soc Belg Med Trop 1984;64:425-426.
40. Ulrich R, Lundkvist A, Meisel H, et al.: Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. Vaccine 1998;16:272-280.
41. Vapalahti O, Kallio-Kokko H, Narvanen A, et al.: Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J Med Virol 1995;46:293-303.
42. Yanagihara R, Amyx HL, and Gajdusek DC: Experimental infection with Puumala virus, the etiologic agent of nephropathia epidemica, in bank voles (Clethrionomys glareolus). J Virol 1985;55:34-38.